Susquehanna International Group’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$71.7K Buy
89,620
+56,451
+170% +$45.2K ﹤0.01% 5969
2025
Q1
$30.4K Sell
33,169
-25,869
-44% -$23.7K ﹤0.01% 6099
2024
Q4
$56.1K Buy
59,038
+38,719
+191% +$36.8K ﹤0.01% 5841
2024
Q3
$25.8K Buy
+20,319
New +$25.8K ﹤0.01% 5378
2024
Q2
Hold
0
5765
2024
Q1
Sell
-90,093
Closed -$105K 5693
2023
Q4
$105K Buy
90,093
+31,091
+53% +$36.4K ﹤0.01% 5326
2023
Q3
$51.3K Buy
59,002
+21,662
+58% +$18.8K ﹤0.01% 5114
2023
Q2
$41.8K Buy
37,340
+1,156
+3% +$1.3K ﹤0.01% 5239
2023
Q1
$37.6K Buy
36,184
+16,580
+85% +$17.2K ﹤0.01% 5502
2022
Q4
$22K Sell
19,604
-116,415
-86% -$130K ﹤0.01% 5349
2022
Q3
$154K Sell
136,019
-31,391
-19% -$35.5K ﹤0.01% 4990
2022
Q2
$246K Buy
167,410
+63,572
+61% +$93.4K ﹤0.01% 4273
2022
Q1
$238K Sell
103,838
-173,012
-62% -$397K ﹤0.01% 4620
2021
Q4
$761K Sell
276,850
-99,959
-27% -$275K ﹤0.01% 3217
2021
Q3
$2.26M Buy
376,809
+339,054
+898% +$2.03M ﹤0.01% 1833
2021
Q2
$184K Sell
37,755
-107,325
-74% -$523K ﹤0.01% 4881
2021
Q1
$358K Buy
145,080
+117,923
+434% +$291K ﹤0.01% 4186
2020
Q4
$74K Buy
27,157
+3,633
+15% +$9.9K ﹤0.01% 4557
2020
Q3
$36K Sell
23,524
-77,858
-77% -$119K ﹤0.01% 4256
2020
Q2
$191K Sell
101,382
-464,892
-82% -$876K ﹤0.01% 3726
2020
Q1
$963K Buy
566,274
+256,514
+83% +$436K ﹤0.01% 2088
2019
Q4
$898K Buy
+309,760
New +$898K ﹤0.01% 2001
2019
Q1
Hold
0
3225
2018
Q4
Sell
-22,721
Closed -$140K 3809
2018
Q3
$140K Buy
+22,721
New +$140K ﹤0.01% 2865
2018
Q2
Hold
0
3774
2018
Q1
Hold
0
3515
2017
Q1
Sell
-13,070
Closed -$117K 3402
2016
Q4
$117K Buy
+13,070
New +$117K ﹤0.01% 3863